CBPP Spotlight Live January 2021: Solid Tumors | Case-Based Peer Perspectives Spotlight Live

KEY OPINION LEADERS REVIEW CASE SCENARIOS IN TARGETED ONCOLOGYTM LIVE DISCUSSIONS

Vaishampayan Discusses Phase 3 Trial Results in mCRPC

February 16, 2021

Clinical Articles

During a Targeted Oncology Case-Based Peer Perspectives event, Ulka Nitin Vaishampayan, MBBS, FAB, discussed the case of a 72-year-old patients with metastatic castration-resistant prostate cancer.

PD-L1 Status Affects Physician’s Choice of Treatment in Lung Cancer

February 13, 2021

Clinical Articles

For the treatment of patients with lung cancer and low PD-L1 expression, immunotherapy-based combinations have been shown effective through clinical trial research. Stephen Liu, MD, reviewed the studies during a Targeted Oncology Case-Based Peer Perspectives virtual event.

Expert Discusses HER2 Selective Kinase Inhibitors in Heavily Pretreated Breast Cancer

February 08, 2021

Clinical Articles

During a Targeted Oncology Case-Based Peer Perspectives virtual event, Lee Schwartzberg, MD, medical oncologist, West Cancer Center and Research Institute, discussed the therapeutic options for a 39-year-old woman with HER2-positive breast cancer who was heavily pretreated.

Trial Results Show Patients With RET Alterations Experience Different Efficacy With Lung Cancer Therapies

February 03, 2021

Clinical Articles

During a Targeted Oncology Case-Based Peer Perspectives event, Todd Bauer, MD, medical oncologist, Tennessee Oncology, discussed the results from clinical trials that include patients with RET-altered lung cancer to determine a treatment strategy for a 59-year-old patient.

Rabinowits Analyzes the Use of Anti–PD-1 Therapy in cSCC

February 01, 2021

Clinical Articles

During a Targeted Oncology Case-Based Peer Perspectives event, Guilherme Rabinowits, MD, medical oncologist/hematologist, Miami Cancer Institute, discussed the case of 69-year-old patients with cutaneous squamous cell carcinoma.

Physicians Have Multiple Choices of Treatment in the Nonmetastatic CRPC Setting

January 31, 2021

Clinical Articles

During a Targeted Oncology Case-Based Peer Perspectives Roundtable, Tanya Dorff, MD, reviews the available treatment options for nonmetastatic castration-resistant prostate cancer to select a treatment for 57-year-old patient.